CNMD Earnings & Financial Statements
CONMED Corporation
$44.66
+$0.43(+0.97%)
68
Overall
100
Value
50
Tech
55
Quality
Market Cap
$1.32B
Volume
69.79K
52W Range
$31.44 - $53.66
Target Price
$46.00
CNMD earnings and financial statements: CONMED Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
CNMD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B |
| Cost of revenue | $624.25M | $573.98M | $568.50M | $474.23M | $442.60M |
| Operating income | $102.62M | $200.33M | $120.60M | $70.05M | $109.72M |
| EBITDA | $182.13M | $277.88M | $198.53M | $32.47M | $179.33M |
| Net income | $47.05M | $132.42M | $64.46M | -$80.58M | $62.54M |
| EPS (diluted) | $1.51 | $4.25 | $2.04 | $-2.68 | $1.94 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.33B | $2.31B | $2.30B | $2.30B | $1.77B |
| Total liabilities | $1.29B | $1.34B | $1.47B | $1.55B | $980.58M |
| Shareholders’ equity | $1.03B | $962.68M | $834.22M | $745.54M | $785.43M |
| Long-term debt | $834.23M | $905.07M | $973.14M | $985.08M | $672.41M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $170.69M | $166.97M | $125.35M | $33.37M | $111.77M |
| Capital expenditure | -$19.81M | -$13.08M | -$19.03M | -$21.79M | -$14.87M |
| Free cash flow | $150.88M | $153.88M | $106.32M | $11.58M | $96.90M |
| Dividends paid | $24.75M | $24.65M | $24.50M | - | $23.26M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNMD | $44.66 | +1.0% | 69.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |